{"title":"新型和传统h3拮抗剂与参与豚鼠回肠神经源性和肌源性收缩反应的非组胺能受体的相互作用","authors":"","doi":"10.1046/j.1365-2680.1999.00111.x","DOIUrl":null,"url":null,"abstract":"<p> <b>1</b> Possible effects of new and conventional H<sub>3</sub>-receptor antagonists towards various non-histaminergic receptors (α<sub>2</sub>-adrenergic, 5-HT<sub>3</sub>-serotonin, μ-opiate, A<sub>1</sub>-adenosine, M<sub>1</sub>-and M<sub>3</sub>-muscarinic) involved in neurogenic and myogenic contractile responses of guinea-pig ileum are investigated.</p><p> <b>2</b> When the isolated ileum was contracted by the 5-HT<sub>3</sub> receptor agonist, 2-methyl-5-HT (5 × 10<sup>−−7</sup>–8 × 10<sup>−−6</sup> <span>m</span>), acetylcholine (1 × 10<sup>−−9</sup>–1 × 10<sup>−−7</sup> <span>m</span>), KCl (3 × 10<sup>−−2</sup> <span>m</span>) or electrical stimulation some of the drugs, included thioperamide and clobenpropit, reduced the contractile response when tested at micromolar concentrations (1–3 × 10<sup>−−5</sup> <span>m</span>) (only compound IV exhibited an M<sub>3</sub> competitive antagonism with a pK<sub>B</sub> = 5.49 <i>±</i> 0.18).</p><p> <b>3</b> Ileal twitch responses to electrical stimulation were dose-dependently inhibited by the selective agonists clonidine (3 × 10<sup>−−10</sup>–1 × 10<sup>−−7</sup> <span>m</span>), dermorphin (1 × 10<sup>−−11</sup>–1 × 10<sup>−−8</sup> <span>m</span>), R-N<sup>6</sup>-(2-phenylisopropyl)-adenosine (1 × 10<sup>−−9</sup>–3 × 10<sup>−−8</sup> <span>m</span>) and McN-A-343 (1 × 10<sup>−−7</sup>–1 × 10<sup>−−5</sup> <span>m</span>) with different potencies and comparable efficacy (spike amplitude reduction > 85%). All the H<sub>3</sub> antagonists under study (up to 1 × 10<sup>−−5</sup> <span>m</span>) showed no or minor interactions at the neuronal sites except the compound V which behaved as a weak competitive antagonist at α<sub>2</sub>-adrenoreceptors (pK<sub>B</sub> = 5.96 ± 0.06).</p><p> <b>4</b> In conclusion, both new and conventional H<sub>3</sub>-blockers interacted at the enteric neuronal sites here studied with a 1000–30 000 fold lower antagonistic potency than that previously reported for the ileal H<sub>3</sub> histamine receptors. Their spasmolytic activity precludes firm conclusions about the non-competitive interaction with 5-HT<sub>3</sub> ileal receptor which requires further investigations.</p>","PeriodicalId":100151,"journal":{"name":"Autonomic and Autacoid Pharmacology","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2008-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1046/j.1365-2680.1999.00111.x","citationCount":"7","resultStr":"{\"title\":\"Interactions of new and conventional H3-antagonists with non-histaminergic receptors involved in neurogenic and myogenic contractile responses of guinea-pig ileum\",\"authors\":\"\",\"doi\":\"10.1046/j.1365-2680.1999.00111.x\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p> <b>1</b> Possible effects of new and conventional H<sub>3</sub>-receptor antagonists towards various non-histaminergic receptors (α<sub>2</sub>-adrenergic, 5-HT<sub>3</sub>-serotonin, μ-opiate, A<sub>1</sub>-adenosine, M<sub>1</sub>-and M<sub>3</sub>-muscarinic) involved in neurogenic and myogenic contractile responses of guinea-pig ileum are investigated.</p><p> <b>2</b> When the isolated ileum was contracted by the 5-HT<sub>3</sub> receptor agonist, 2-methyl-5-HT (5 × 10<sup>−−7</sup>–8 × 10<sup>−−6</sup> <span>m</span>), acetylcholine (1 × 10<sup>−−9</sup>–1 × 10<sup>−−7</sup> <span>m</span>), KCl (3 × 10<sup>−−2</sup> <span>m</span>) or electrical stimulation some of the drugs, included thioperamide and clobenpropit, reduced the contractile response when tested at micromolar concentrations (1–3 × 10<sup>−−5</sup> <span>m</span>) (only compound IV exhibited an M<sub>3</sub> competitive antagonism with a pK<sub>B</sub> = 5.49 <i>±</i> 0.18).</p><p> <b>3</b> Ileal twitch responses to electrical stimulation were dose-dependently inhibited by the selective agonists clonidine (3 × 10<sup>−−10</sup>–1 × 10<sup>−−7</sup> <span>m</span>), dermorphin (1 × 10<sup>−−11</sup>–1 × 10<sup>−−8</sup> <span>m</span>), R-N<sup>6</sup>-(2-phenylisopropyl)-adenosine (1 × 10<sup>−−9</sup>–3 × 10<sup>−−8</sup> <span>m</span>) and McN-A-343 (1 × 10<sup>−−7</sup>–1 × 10<sup>−−5</sup> <span>m</span>) with different potencies and comparable efficacy (spike amplitude reduction > 85%). All the H<sub>3</sub> antagonists under study (up to 1 × 10<sup>−−5</sup> <span>m</span>) showed no or minor interactions at the neuronal sites except the compound V which behaved as a weak competitive antagonist at α<sub>2</sub>-adrenoreceptors (pK<sub>B</sub> = 5.96 ± 0.06).</p><p> <b>4</b> In conclusion, both new and conventional H<sub>3</sub>-blockers interacted at the enteric neuronal sites here studied with a 1000–30 000 fold lower antagonistic potency than that previously reported for the ileal H<sub>3</sub> histamine receptors. Their spasmolytic activity precludes firm conclusions about the non-competitive interaction with 5-HT<sub>3</sub> ileal receptor which requires further investigations.</p>\",\"PeriodicalId\":100151,\"journal\":{\"name\":\"Autonomic and Autacoid Pharmacology\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2008-10-09\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1046/j.1365-2680.1999.00111.x\",\"citationCount\":\"7\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Autonomic and Autacoid Pharmacology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1046/j.1365-2680.1999.00111.x\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Autonomic and Autacoid Pharmacology","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1046/j.1365-2680.1999.00111.x","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Interactions of new and conventional H3-antagonists with non-histaminergic receptors involved in neurogenic and myogenic contractile responses of guinea-pig ileum
1 Possible effects of new and conventional H3-receptor antagonists towards various non-histaminergic receptors (α2-adrenergic, 5-HT3-serotonin, μ-opiate, A1-adenosine, M1-and M3-muscarinic) involved in neurogenic and myogenic contractile responses of guinea-pig ileum are investigated.
2 When the isolated ileum was contracted by the 5-HT3 receptor agonist, 2-methyl-5-HT (5 × 10−−7–8 × 10−−6m), acetylcholine (1 × 10−−9–1 × 10−−7m), KCl (3 × 10−−2m) or electrical stimulation some of the drugs, included thioperamide and clobenpropit, reduced the contractile response when tested at micromolar concentrations (1–3 × 10−−5m) (only compound IV exhibited an M3 competitive antagonism with a pKB = 5.49 ± 0.18).
3 Ileal twitch responses to electrical stimulation were dose-dependently inhibited by the selective agonists clonidine (3 × 10−−10–1 × 10−−7m), dermorphin (1 × 10−−11–1 × 10−−8m), R-N6-(2-phenylisopropyl)-adenosine (1 × 10−−9–3 × 10−−8m) and McN-A-343 (1 × 10−−7–1 × 10−−5m) with different potencies and comparable efficacy (spike amplitude reduction > 85%). All the H3 antagonists under study (up to 1 × 10−−5m) showed no or minor interactions at the neuronal sites except the compound V which behaved as a weak competitive antagonist at α2-adrenoreceptors (pKB = 5.96 ± 0.06).
4 In conclusion, both new and conventional H3-blockers interacted at the enteric neuronal sites here studied with a 1000–30 000 fold lower antagonistic potency than that previously reported for the ileal H3 histamine receptors. Their spasmolytic activity precludes firm conclusions about the non-competitive interaction with 5-HT3 ileal receptor which requires further investigations.